Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
Thiazolidinediones (TZDs) are synthetic PPARγ (peroxisome proliferator-activated receptor gamma) agonists and a class of drugs for diabetes mellitus type 2 that can decrease blood sugar efficiently by enhancing insulin sensitivity. However, increased bone fracture risk in diabetic individuals treate...
Saved in:
Main Authors: | Wei Wei, Yihong Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2011/867180 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
Fine-Tuning Reception in the Bone: PPARγ and Company
by: Z. Elizabeth Floyd, et al.
Published: (2006-01-01) -
PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01) -
The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)